BTIG Research Cuts Simulations Plus (NASDAQ:SLP) Price Target to $25.00

Simulations Plus (NASDAQ:SLP - Get Free Report) had its price objective decreased by research analysts at BTIG Research from $41.00 to $25.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has a "buy" rating on the technology company's stock. BTIG Research's price target suggests a potential upside of 48.54% from the stock's previous close.

A number of other brokerages have also recently issued reports on SLP. KeyCorp increased their target price on Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a report on Wednesday, April 16th. William Blair reaffirmed an "outperform" rating on shares of Simulations Plus in a research note on Tuesday, June 3rd. JMP Securities reaffirmed a "market perform" rating on shares of Simulations Plus in a research note on Wednesday, June 18th. Craig Hallum dropped their price objective on shares of Simulations Plus from $45.00 to $36.00 and set a "buy" rating on the stock in a research note on Friday, June 13th. Finally, Wall Street Zen upgraded Simulations Plus from a "sell" rating to a "hold" rating in a research note on Monday, April 28th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $35.00.

Simulations Plus Stock Down 5.2%

Shares of SLP traded down $0.92 during mid-day trading on Monday, hitting $16.83. 472,496 shares of the company's stock were exchanged, compared to its average volume of 260,272. Simulations Plus has a 52 week low of $16.72 and a 52 week high of $44.33. The firm has a market cap of $338.45 million, a price-to-earnings ratio of 48.09 and a beta of 0.83. The stock's 50-day simple moving average is $26.47 and its 200-day simple moving average is $28.76.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a net margin of 9.18% and a return on equity of 7.86%. The firm had revenue of $22.43 million for the quarter, compared to analysts' expectations of $21.93 million. During the same quarter in the previous year, the firm posted $0.20 earnings per share. The company's revenue was up 22.5% on a year-over-year basis. Analysts forecast that Simulations Plus will post 1.09 earnings per share for the current fiscal year.

Insider Buying and Selling at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $33.51, for a total transaction of $670,200.00. Following the sale, the director directly owned 3,344,157 shares in the company, valued at approximately $112,062,701.07. This trade represents a 0.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 19.40% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Rhumbline Advisers lifted its holdings in Simulations Plus by 2.1% in the 1st quarter. Rhumbline Advisers now owns 66,222 shares of the technology company's stock worth $1,624,000 after purchasing an additional 1,334 shares in the last quarter. Woodline Partners LP boosted its holdings in shares of Simulations Plus by 32.1% during the 1st quarter. Woodline Partners LP now owns 13,239 shares of the technology company's stock valued at $325,000 after purchasing an additional 3,220 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new position in Simulations Plus during the first quarter valued at approximately $255,000. Uniplan Investment Counsel Inc. boosted its stake in Simulations Plus by 141.8% during the first quarter. Uniplan Investment Counsel Inc. now owns 144,202 shares of the technology company's stock valued at $3,536,000 after buying an additional 84,562 shares during the last quarter. Finally, NFJ Investment Group LLC bought a new position in shares of Simulations Plus during the 1st quarter valued at approximately $1,254,000. 78.08% of the stock is owned by hedge funds and other institutional investors.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.